Global mRNA Drug Industry

Global mRNA Drug Industry Research & Trends Analysis Report

Global mRNA Drug Industry

Global mRNA Drug Industry Research & Trends Analysis Report


Analysis of the mRNA Drug Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Latest Research Study, the global market for mRNA Drug should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China mRNA Drug market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States mRNA Drug market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Preventive Vaccines segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of mRNA Drug include Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca and Janssen, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.

This report aims to provide a comprehensive study of the global market for mRNA Drug.
Report Highlights:

(1) Global mRNA Drug market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.

(2) Global mRNA Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China mRNA Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global mRNA Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global mRNA Drug segment by type and by application and regional segment by type and by application.

(6) Global major production regions of mRNA Drug, capacity, production and trends.

(7) mRNA Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Preventive Vaccines

Therapeutic Vaccine

Therapeutic Drugs

Market segment by application, can be divided into

Hospital

Clinic

Market segment by players, this report covers

Moderna

Pfizer

Zydus Cadila

Fosun Pharma

CureVAC

Sri Lankan Microorganisms

BioNtech

AstraZeneca

Janssen

1 Market Overview

1.1 mRNA Drug Definition

1.2 Global mRNA Drug Market Size and Forecast

1.2.1 By Revenue, Global mRNA Drug Market Size, 2019-2030

1.2.2 By Sales Volume, Global mRNA Drug Market Size, 2019-2030

1.2.3 Global mRNA Drug Price Trend, 2019-2030

1.3 China mRNA Drug Market Size and Forecast

1.3.1 By Revenue, China mRNA Drug Market Size, 2019-2030

1.3.2 By Sales Volume, China mRNA Drug Market Size, 2019-2030

1.3.3 China mRNA Drug Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China mRNA Drug Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China mRNA Drug Share in Global Market, 2019-2030

1.4.3 mRNA Drug Market Size: China VS Global, 2019-2030

1.5 mRNA Drug Market Dynamics

1.5.1 mRNA Drug Market Drivers

1.5.2 mRNA Drug Market Restraints

1.5.3 mRNA Drug Industry Trends

1.5.4 mRNA Drug Industry Policy

2 Global Competitive Landscape by Company

2.1 Global mRNA Drug Revenue by Company, 2019-2024

2.2 Global mRNA Drug Sales Volume by Company, 2019-2024

2.3 Global mRNA Drug Price by Company, 2019-2024

2.4 Global mRNA Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global mRNA Drug Concentration Ratio

2.6 Global mRNA Drug Mergers & Acquisitions, Expansion Plans

2.7 Global mRNA Drug Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China mRNA Drug Revenue by Company, 2019-2024

3.2 China mRNA Drug Sales Volume by Company, 2019-2024

3.3 China mRNA Drug mRNA Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China mRNA Drug Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, mRNA Drug Domestic VS Export

3.6 China Market, mRNA Drug Import & Export

3.6.1 China Market, mRNA Drug Import & Export, 2019-2030

3.6.2 China mRNA Drug Import & Export Trends

3.6.3 Main Sources of China mRNA Drug Import

3.6.4 Export Destination of China mRNA Drug

4 mRNA Drug Production by Region

4.1 Global mRNA Drug Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of mRNA Drug Manufacturers

4.3 Global Major Manufacturers, mRNA Drug Capacity Expansion and Future Plans

4.4 Global mRNA Drug Capacity by Region

4.5 Global mRNA Drug Production by Region

4.5.1 Global mRNA Drug Production & Forecast by Region, 2019 VS 2024 VS 2030

4.5.2 Global mRNA Drug Production by Region, 2019-2024

4.5.3 Global mRNA Drug Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 mRNA Drug Industry Chain

5.2 mRNA Drug Upstream Analysis

5.2.1 mRNA Drug Core Raw Materials

5.2.2 Main Manufacturers of mRNA Drug Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 mRNA Drug Production Mode

5.6 mRNA Drug Procurement Model

5.7 mRNA Drug Industry Sales Model and Sales Channels

5.7.1 mRNA Drug Sales Model

5.7.2 mRNA Drug Typical Distributors

6 Sights by Type

6.1 mRNA Drug Classification

6.1.1 Preventive Vaccines

6.1.2 Therapeutic Vaccine

6.1.3 Therapeutic Drugs

6.2 By Type, Global mRNA Drug Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global mRNA Drug Revenue, 2019-2030

6.4 By Type, Global mRNA Drug Sales Volume, 2019-2030

6.5 By Type, Global mRNA Drug Price, 2019-2030

7 Sights by Application

7.1 mRNA Drug Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.2 By Application, Global mRNA Drug Market Size & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global mRNA Drug Revenue, 2019-2030

7.4 By Application, Global mRNA Drug Sales Volume, 2019-2030

7.5 By Application, Global mRNA Drug Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global mRNA Drug Market Size, 2019 VS 2024 VS 2030

8.2 By Region, Global mRNA Drug Revenue, 2019-2030

8.3 By Region, Global mRNA Drug Sales Volume, 2019-2030

8.4 North America

8.4.1 North America mRNA Drug Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America mRNA Drug Market Size Market Share

8.5 Europe

8.5.1 Europe mRNA Drug Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe mRNA Drug Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific mRNA Drug Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific mRNA Drug Market Size Market Share

8.7 South America

8.7.1 South America mRNA Drug Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America mRNA Drug Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global mRNA Drug Market Size & CAGR，2019 VS 2024 VS 2030

9.2 By Country, Global mRNA Drug Revenue, 2019-2030

9.3 By Country, Global mRNA Drug Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. mRNA Drug Market Size, 2019-2030

9.4.2 By Company, U.S. mRNA Drug Sales Volume Market Share, 2024

9.4.3 By Type, U.S. mRNA Drug Market Size, Share, 2024 VS 2030

9.4.4 By Application, U.S. mRNA Drug Market Size, Share, 2024 VS 2030

9.5 Europe

9.5.1 Europe mRNA Drug Market Size, 2019-2030

9.5.2 By Company, Europe mRNA Drug Sales Volume Market Share, 2024

9.5.3 By Type, Europe mRNA Drug Market Size, Share, 2024 VS 2030

9.5.4 By Application, Europe mRNA Drug Market Size, Share, 2024 VS 2030

9.6 China

9.6.1 China mRNA Drug Market Size, 2019-2030

9.6.2 By Company, China mRNA Drug Sales Volume Market Share, 2024

9.6.3 By Type, China mRNA Drug Market Size, Share, 2024 VS 2030

9.6.4 By Application, China mRNA Drug Market Size, Share, 2024 VS 2030

9.7 Japan

9.7.1 Japan mRNA Drug Market Size, 2019-2030

9.7.2 By Company, Japan mRNA Drug Sales Volume Market Share, 2024

9.7.3 By Type, Japan mRNA Drug Market Size, Share, 2024 VS 2030

9.7.4 By Application, Japan mRNA Drug Market Size, Share, 2024 VS 2030

9.8 South Korea

9.8.1 South Korea mRNA Drug Market Size, 2019-2030

9.8.2 By Company, South Korea mRNA Drug Sales Volume Market Share, 2024

9.8.3 By Type, South Korea mRNA Drug Market Size, Share, 2024 VS 2030

9.8.4 By Application, South Korea mRNA Drug Market Size, Share, 2024 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia mRNA Drug Market Size, 2019-2030

9.9.2 By Company, Southeast Asia mRNA Drug Sales Volume Market Share, 2024

9.9.3 By Type, Southeast Asia mRNA Drug Market Size, Share, 2024 VS 2030

9.9.4 By Application, Southeast Asia mRNA Drug Market Size, Share, 2024 VS 2030

9.10 India

9.10.1 India mRNA Drug Market Size, 2019-2030

9.10.2 By Company, India mRNA Drug Sales Volume Market Share, 2024

9.10.3 By Type, India mRNA Drug Market Size, Share, 2024 VS 2030

9.10.4 By Application, India mRNA Drug Market Size, Share, 2024 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia mRNA Drug Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia mRNA Drug Sales Volume Market Share, 2024

9.11.3 By Type, Middle East & Asia mRNA Drug Market Size, Share, 2024 VS 2030

9.11.4 By Application, Middle East & Asia mRNA Drug Market Size, Share, 2024 VS 2030

10 Manufacturers Profile

10.1 Moderna

10.1.1 Moderna Company Information, Head Office, Market Area and Industry Position

10.1.2 Moderna mRNA Drug Models, Specifications and Application

10.1.3 Moderna mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Moderna Company Profile and Main Business

10.1.5 Moderna Recent Developments

10.2 Pfizer

10.2.1 Pfizer Company Information, Head Office, Market Area and Industry Position

10.2.2 Pfizer mRNA Drug Models, Specifications and Application

10.2.3 Pfizer mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Pfizer Company Profile and Main Business

10.2.5 Pfizer Recent Developments

10.3 Zydus Cadila

10.3.1 Zydus Cadila Company Information, Head Office, Market Area and Industry Position

10.3.2 Zydus Cadila mRNA Drug Models, Specifications and Application

10.3.3 Zydus Cadila mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Zydus Cadila Company Profile and Main Business

10.3.5 Zydus Cadila Recent Developments

10.4 Fosun Pharma

10.4.1 Fosun Pharma Company Information, Head Office, Market Area and Industry Position

10.4.2 Fosun Pharma mRNA Drug Models, Specifications and Application

10.4.3 Fosun Pharma mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Fosun Pharma Company Profile and Main Business

10.4.5 Fosun Pharma Recent Developments

10.5 CureVAC

10.5.1 CureVAC Company Information, Head Office, Market Area and Industry Position

10.5.2 CureVAC mRNA Drug Models, Specifications and Application

10.5.3 CureVAC mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 CureVAC Company Profile and Main Business

10.5.5 CureVAC Recent Developments

10.6 Sri Lankan Microorganisms

10.6.1 Sri Lankan Microorganisms Company Information, Head Office, Market Area and Industry Position

10.6.2 Sri Lankan Microorganisms mRNA Drug Models, Specifications and Application

10.6.3 Sri Lankan Microorganisms mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Sri Lankan Microorganisms Company Profile and Main Business

10.6.5 Sri Lankan Microorganisms Recent Developments

10.7 BioNtech

10.7.1 BioNtech Company Information, Head Office, Market Area and Industry Position

10.7.2 BioNtech mRNA Drug Models, Specifications and Application

10.7.3 BioNtech mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 BioNtech Company Profile and Main Business

10.7.5 BioNtech Recent Developments

10.8 AstraZeneca

10.8.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

10.8.2 AstraZeneca mRNA Drug Models, Specifications and Application

10.8.3 AstraZeneca mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 AstraZeneca Company Profile and Main Business

10.8.5 AstraZeneca Recent Developments

10.9 Janssen

10.9.1 Janssen Company Information, Head Office, Market Area and Industry Position

10.9.2 Janssen mRNA Drug Models, Specifications and Application

10.9.3 Janssen mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Janssen Company Profile and Main Business

10.9.5 Janssen Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
mRNA Drug Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the mRNA Drug Market trending toward high growth trajectories?
A dynamic process in the mRNA Drug Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Moderna, BioNTech, Pfizer, CureVac, Sanofi, GSK, AstraZeneca, Merck, Translate Bio, Arcturus Therapeutics, eTheRNA, Kernal Biologics, Acuitas Therapeutics, RNAimmune, Replicate Bioscience, Tiba Biotech, Strand Therapeutics, GreenLight Biosciences, HDT Bio, Daiichi Sankyo.
How are players chosen for the research coverage of the mRNA Drug Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What are the major applications of the mRNA Drug Market?
Depending upon the type of applications, the mRNA Drug Market has been segmented into and other applications.
What is the size of the mRNA Drug Industry?
According to the report, the mRNA Drug Industry will grow to USD XXX Million by 2030, with a YY% CAGR.
What trends may have an impact on the mRNA Drug Market's growth?
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the mRNA Drug Market as well as its distribution among its players
What is the estimated global market value of the mRNA Drug Market?
The mRNA Drug Market is expected to reach a considerable market valuation.